Samsung invests in Swedish app

 

Bloomberg

Samsung Electronics Co joined the latest funding round for Swedish fertility tracking app Natural Cycles as lead investor, seeking to introduce the female-health technology to its Galaxy series smartwatches.
The Natural Cycles app, which monitors body temperature to gauge fertility, in 2018 became the first contraceptive of its kind to be approved by the US Food and Drug Administration (FDA).
Samsung expects to introduce the app on Galaxy Watch5 devices in the second quarter, with its investment part of a $7 million funding round for NaturalCycles Nordic AB.
The company, founded by physicist Elina Berglund and her husband Raoul Scherwitzl, raised a “modest” amount as it prioritised bringing in “strategic partners” to help expand the number of measuring options, Scherwitzl said.

Leave a Reply

Send this to a friend